Tim F. Greten
National Cancer Institute
2 papers in the Anchorcite directory, published between 2008 and 2017, cited 20,022 times in total.
ORCID profileResearch topics
- Colorectal Cancer Treatments and Studies · 1 paper
- Hepatocellular Carcinoma Treatment and Prognosis · 1 paper
- Renal cell carcinoma treatment · 1 paper
- Cancer Immunotherapy and Biomarkers · 1 paper
- Immunotherapy and Immune Responses · 1 paper
- Genetic factors in colorectal cancer · 1 paper
Frequent co-authors
- Josep Maria Llovet · 1 paper
- Sergio Ricci · 1 paper
- Vincenzo Mazzaferro · 1 paper
- Philip a. Hilgard · 1 paper
- Edward John Gane · 1 paper
- Jean Frédéric Blanc · 1 paper
- André Cosme de Oliveira · 1 paper
- Armando Santoro · 1 paper
Papers
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine · 2008 · 13,250 citations
BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in…
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeScience · 2017 · 6,772 citations
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death…
Metadata from OpenAlex (CC0).